MX2009001412A - Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas. - Google Patents
Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas.Info
- Publication number
- MX2009001412A MX2009001412A MX2009001412A MX2009001412A MX2009001412A MX 2009001412 A MX2009001412 A MX 2009001412A MX 2009001412 A MX2009001412 A MX 2009001412A MX 2009001412 A MX2009001412 A MX 2009001412A MX 2009001412 A MX2009001412 A MX 2009001412A
- Authority
- MX
- Mexico
- Prior art keywords
- vaccines
- methods
- making
- administering
- protein matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0283—Shigella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
- A61K2039/645—Dendrimers; Multiple antigen peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
La invención se refiere a composiciones de vacuna teniendo una proteína portadora y un antígeno de interés atrapado en un complejo, métodos para hacer tales vacunas, y métodos de administración de vacuna.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83594406P | 2006-08-07 | 2006-08-07 | |
US93376407P | 2007-06-08 | 2007-06-08 | |
PCT/US2007/017528 WO2008021076A2 (en) | 2006-08-07 | 2007-08-07 | Protein matrix vaccines and methods of making and administering such vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009001412A true MX2009001412A (es) | 2009-04-24 |
Family
ID=39082551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009001412A MX2009001412A (es) | 2006-08-07 | 2007-08-07 | Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas. |
Country Status (12)
Country | Link |
---|---|
US (3) | US8642042B2 (es) |
EP (2) | EP2056871B1 (es) |
JP (2) | JP5745221B2 (es) |
KR (1) | KR101446238B1 (es) |
AU (1) | AU2007284878B2 (es) |
BR (1) | BRPI0715396B8 (es) |
CA (1) | CA2660022C (es) |
DK (1) | DK2056871T3 (es) |
ES (1) | ES2658851T3 (es) |
MX (1) | MX2009001412A (es) |
TW (1) | TWI565713B (es) |
WO (1) | WO2008021076A2 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009001412A (es) * | 2006-08-07 | 2009-04-24 | Harvard College | Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas. |
US8524394B2 (en) * | 2007-11-22 | 2013-09-03 | Samsung Sdi Co., Ltd. | Negative electrode and negative active material for rechargeable lithium battery, and rechargeable lithium battery including same |
US8728478B2 (en) | 2008-09-03 | 2014-05-20 | Board Of Trustees Of Michigan State University | Immunogenic Escherichia coli heat stable enterotoxin |
US8647621B2 (en) | 2009-07-27 | 2014-02-11 | Fina Biosolutions, Llc | Method of producing protein-carbohydrate vaccines reduced in free carbohydrate |
US20120231086A1 (en) * | 2009-09-09 | 2012-09-13 | Killen Kevin P | Protein matrix vaccines of improved immunogenicity |
US20110135689A1 (en) * | 2009-11-30 | 2011-06-09 | University Of Iowa Research Foundation | Vaccine, therapeutic composition and methods for treating or inhibiting francisella tularenis |
JP5892944B2 (ja) | 2009-12-17 | 2016-03-23 | フィナ バイオソリューションズ リミテッド ライアビリティ カンパニー | コンジュゲートワクチンの製造における多糖の活性化のための化学試薬 |
EP2560738B8 (en) | 2010-04-23 | 2019-09-25 | Serum Institute of India Private Limited | Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels |
CN102858370A (zh) * | 2010-05-03 | 2013-01-02 | Dcb-美国有限责任公司 | 用作疫苗的多糖与去毒大肠杆菌(e.coli)不耐热肠毒素(lt)的偶联 |
EP3524265A1 (en) | 2011-05-18 | 2019-08-14 | Matrivax, Inc. | Protein matrix vaccine compositions including polycations |
ES2757473T3 (es) | 2011-09-30 | 2020-04-29 | Dana Farber Cancer Inst Inc | Péptidos terapéuticos que comprenden anticuerpos que se unen a la secuencia A relacionada con el polipéptido del CMH de clase I (MICA) |
EP2946010B1 (en) | 2013-01-18 | 2018-08-29 | London School of Hygiene and Tropical Medicine | Glycosylation method |
GB201301085D0 (en) | 2013-01-22 | 2013-03-06 | London School Hygiene & Tropical Medicine | Glycoconjugate Vaccine |
US10745483B2 (en) | 2013-03-15 | 2020-08-18 | Dana-Farber Cancer Institute, Inc. | Therapeutic peptides |
WO2015073831A1 (en) * | 2013-11-15 | 2015-05-21 | Liquidia Technologies, Inc. | Virtual conjugate particles |
CA2937184A1 (en) | 2014-01-21 | 2015-07-30 | Pfizer Inc. | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
CA2945822A1 (en) * | 2014-05-21 | 2015-11-26 | Dana-Farber Cancer Institute, Inc. | Methods for treating cancer with anti bip or anti mica antibodies |
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
WO2018009906A1 (en) * | 2016-07-08 | 2018-01-11 | President And Fellows Of Harvard College | Whole cell-protein conjugates and methods of making the same |
CN109890413B (zh) | 2016-09-02 | 2024-04-16 | 赛诺菲巴斯德股份有限公司 | 脑膜炎奈瑟氏菌疫苗 |
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
BR112019026192B1 (pt) * | 2017-06-10 | 2022-05-10 | Inventprise, Llc | Vacinas de conjugado multivalente com polissacarídeos de conjugado bivalente ou multivalente que fornecem imunogenicidade e avidez melhoradas |
US11541110B2 (en) | 2017-10-13 | 2023-01-03 | The Research Foundation For The State University Of New York | Comprehensive vaccine design for commensal disease progression |
SG11202005255PA (en) | 2017-12-06 | 2020-07-29 | Merck Sharp & Dohme | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
EP3893926A1 (en) * | 2018-12-12 | 2021-10-20 | Pfizer Inc. | Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof |
JP7275277B2 (ja) | 2018-12-19 | 2023-05-17 | メルク・シャープ・アンド・ドーム・エルエルシー | ストレプトコッカス・ニューモニエ多糖-タンパク質コンジュゲートを含む組成物およびその使用方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4707543A (en) * | 1985-09-17 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines |
US4761470A (en) | 1985-12-16 | 1988-08-02 | Merck & Co., Inc. | Immunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibody |
US5153312A (en) * | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
JPH06508108A (ja) | 1991-03-28 | 1994-09-14 | ニユコメド・イメージング・アクシエセルカペト | 化学的化合物 |
US5961970A (en) * | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
US5545669A (en) | 1994-06-02 | 1996-08-13 | Adams; Jerry L. | Anti-inflammatory compounds |
US5917017A (en) | 1994-06-08 | 1999-06-29 | President And Fellows Of Harvard College | Diphtheria toxin vaccines bearing a mutated R domain |
US5565204A (en) | 1994-08-24 | 1996-10-15 | American Cyanamid Company | Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
HUP9901577A3 (en) * | 1995-09-18 | 2000-03-28 | Lowell Georg H Cote St Luc | Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
US6821331B2 (en) * | 2003-04-09 | 2004-11-23 | Wisconsin Alumni Research Foundation | Protein-polysaccharide hybrid hydrogels |
EP1522585A1 (en) * | 2003-10-09 | 2005-04-13 | Plant Research International B.V. | Chimeric carrier molecules for the production of mucosal vaccines |
MX2009001412A (es) * | 2006-08-07 | 2009-04-24 | Harvard College | Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas. |
-
2007
- 2007-08-07 MX MX2009001412A patent/MX2009001412A/es active IP Right Grant
- 2007-08-07 EP EP07836580.6A patent/EP2056871B1/en active Active
- 2007-08-07 AU AU2007284878A patent/AU2007284878B2/en active Active
- 2007-08-07 WO PCT/US2007/017528 patent/WO2008021076A2/en active Application Filing
- 2007-08-07 ES ES07836580.6T patent/ES2658851T3/es active Active
- 2007-08-07 DK DK07836580.6T patent/DK2056871T3/en active
- 2007-08-07 EP EP17168648.8A patent/EP3260134A1/en not_active Withdrawn
- 2007-08-07 JP JP2009523818A patent/JP5745221B2/ja active Active
- 2007-08-07 TW TW096128983A patent/TWI565713B/zh active
- 2007-08-07 KR KR1020097004799A patent/KR101446238B1/ko active IP Right Grant
- 2007-08-07 CA CA2660022A patent/CA2660022C/en active Active
- 2007-08-07 US US11/890,565 patent/US8642042B2/en active Active
- 2007-08-07 BR BRPI0715396A patent/BRPI0715396B8/pt active IP Right Grant
-
2013
- 2013-10-25 JP JP2013221989A patent/JP2014058530A/ja active Pending
- 2013-12-27 US US14/142,221 patent/US9216223B2/en active Active
-
2015
- 2015-11-24 US US14/950,113 patent/US9533032B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20080095803A1 (en) | 2008-04-24 |
WO2008021076A3 (en) | 2008-12-04 |
EP2056871A4 (en) | 2010-04-14 |
TW200823230A (en) | 2008-06-01 |
JP5745221B2 (ja) | 2015-07-08 |
DK2056871T3 (en) | 2018-02-26 |
US9216223B2 (en) | 2015-12-22 |
JP2010500354A (ja) | 2010-01-07 |
US9533032B2 (en) | 2017-01-03 |
KR101446238B1 (ko) | 2014-10-01 |
US20160136257A1 (en) | 2016-05-19 |
EP3260134A1 (en) | 2017-12-27 |
BRPI0715396B8 (pt) | 2021-05-25 |
CA2660022C (en) | 2014-11-04 |
BRPI0715396B1 (pt) | 2019-02-19 |
AU2007284878B2 (en) | 2013-01-17 |
US8642042B2 (en) | 2014-02-04 |
EP2056871A2 (en) | 2009-05-13 |
KR20090066272A (ko) | 2009-06-23 |
EP2056871B1 (en) | 2017-11-15 |
JP2014058530A (ja) | 2014-04-03 |
ES2658851T3 (es) | 2018-03-12 |
AU2007284878A1 (en) | 2008-02-21 |
CA2660022A1 (en) | 2008-02-21 |
BRPI0715396A2 (pt) | 2013-11-26 |
WO2008021076A2 (en) | 2008-02-21 |
US20140186399A1 (en) | 2014-07-03 |
TWI565713B (zh) | 2017-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009001412A (es) | Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas. | |
CY1123739T1 (el) | Αντισωματα anti-cd38 | |
AU2009326524A8 (en) | Use of Flt3 ligand for strengthening immune responses in RNA immunization | |
MX347893B (es) | Conjugados de farmaco y anticuerpo humano contra factor de tejido. | |
EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
MX363307B (es) | Plataformas para suministro de antigenos. | |
WO2006126981A3 (en) | Compositions and methods for mucosal vaccination | |
WO2005097211A3 (en) | Compositions as adjuvants to improve immune responses to vaccines and methods of use | |
WO2008040362A3 (en) | Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies | |
PH12013502192A1 (en) | Antibodies against human angiopoietin 2 | |
TW200716646A (en) | (S)-N-methylnaltrexone | |
MY169837A (en) | Immunogenic compositions of staphylococcus aureus antigens | |
MY172421A (en) | Immunostimulatory oligonucleotides | |
MX2011003842A (es) | Direccion de celulas que presentan antigeno con inmunonanoterapeuticos. | |
EP1735010A4 (en) | METHODS, COMPOSITIONS AND PREPARATIONS FOR ADMINISTRATION OF IMMUNE RESPONSE MODIFIERS (MRI) | |
EA201100268A1 (ru) | Вакцина | |
MX2010001054A (es) | Composiciones adyuvantes antigenicas y metodos. | |
EA200801460A1 (ru) | Рекомбинантные моновалентные антитела и способы их получения | |
MY150706A (en) | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
WO2008073448A3 (en) | Pharmaceutical formulations and methods for making the same | |
WO2012027365A3 (en) | Targeted multi-epitope dosage forms for induction of an immune response to antigens | |
MA32819B1 (fr) | Vaccin combine notamment contre la coqueluche acellulaire | |
MX2014005372A (es) | Molecula portadora que comprende un antigeno spr0096 y un spr2021. | |
WO2009135199A3 (en) | Vaccine compositions and methods | |
MX349657B (es) | Composiciones de vacuna de matriz de proteína que incluyen policationes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |